Wealthspire Advisors (New York)’s Fennec Pharmaceuticals FENC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-25,000
Closed -$202K 590
2022
Q3
$202K Hold
25,000
﹤0.01% 477
2022
Q2
$141K Hold
25,000
﹤0.01% 480
2022
Q1
$140K Hold
25,000
﹤0.01% 419
2021
Q4
$110K Buy
+25,000
New +$110K ﹤0.01% 525